Decitabine enhances chemosensitivity of early T-cell precursor-acute lymphoblastic leukemia cell lines and patient-derived samples
2016 · Leukemia & lymphoma/Leukemia and lymphoma · 30 citations
https://doi.org/10.3109/10428194.2015.1110747
B
Benjamin Y. Lu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
34
Papers
545
Citations
10
h-index
11
i10-index
Benjamin Y. Lu is an academic researcher from Yale Cancer Center. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Brain Metastases and Treatment & CAR-T cell therapy research. The author has an h-index of 10, co-authored 29 publications.
ORCID: 0000-0001-8764-8384Papers by this author
worksIntracranial Complications From Immune Checkpoint Therapy in a Patient With NSCLC and Multiple Sclerosis: Case Report
2021 · JTO Clinical and Research Reports · 8 citations
https://doi.org/10.1016/j.jtocrr.2021.100183
Circulating Tumor Reactive KIR+CD8+ T cells Suppress Anti-Tumor Immunity in Patients with Melanoma
2024 · Research Square · 0 citations
https://doi.org/10.21203/rs.3.rs-3956671/v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat